AHA Coding Clinic® for HCPCS - 2005 Quarter 3
New C codes effective October 1, 2005
C2637 Brachytherapy source, Ytterbium-169, per source C9224 Injection, Galsulfase, per 5 mg C9225 Fluocinolone acetonide intravitreal long-acting implant, per 0.59 mg C9226 Injection, Ziconotide for intrathecal infusion, per 5 mcg C9725 Brachytherapy ...
Subscribe or sign in to view the full article.
Article Overview
This short reference article summarizes a set of HCPCS Level II C codes that became effective on October 1, 2005. It is intended for coders, billers, and compliance staff who need to identify newly added codes in an update list and understand the scope of the change at a high level. The content is limited to the code identifiers themselves and does not provide detailed coding guidance.
Why This Topic Matters
Release lists like this help coding teams track newly effective HCPCS Level II updates and confirm which identifiers were added for a given date.
What You Will Learn
- Which HCPCS Level II C codes were newly effective in the October 1, 2005 update
- How the article is organized as a simple code list rather than a narrative guidance piece
- The general clinical and service areas represented in the update list
- What kinds of coding content are included in this short update notice
Who Should Read This
- Medical coders
- Billing staff
- Compliance teams
- Healthcare revenue cycle professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com